China Medical & HealthCare Group (ex - COL CAPITAL // ex - China Online) - Facts (Seite 2)
eröffnet am 07.03.16 12:13:23 von
neuester Beitrag 26.01.23 15:26:37 von
neuester Beitrag 26.01.23 15:26:37 von
Beiträge: 26
ID: 1.228.008
ID: 1.228.008
Aufrufe heute: 0
Gesamt: 16.425
Gesamt: 16.425
Aktive User: 0
ISIN: BMG2133H2006 · WKN: A3D63Y · Symbol: SMI
0,0755
EUR
-9,04 %
-0,0075 EUR
Letzter Kurs 10.05.24 Tradegate
Werte aus der Branche Internet
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 12,040 | +24,95 | |
| 2,5400 | +11,40 | |
| 5,2500 | +9,38 | |
| 22,600 | +7,62 | |
| 2,6000 | +7,44 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 84,62 | -10,59 | |
| 8,8980 | -10,82 | |
| 4,9000 | -12,50 | |
| 1,9000 | -22,45 | |
| 6,5500 | -25,78 |
Beitrag zu dieser Diskussion schreiben
Feedback
... und wieder oben 
.... ist da mehr drin?
.... ist da mehr drin?
hab auch noch 28.000 im Depot. Freitag 21% gefallen. Mal abwarten.
Vermutlich Dank dem Corona Virus steigt der Wert stärker an. Der Wert wird aber nach dem "Abflauen" sicher wieder absinken.
Antwort auf Beitrag Nr.: 60.234.370 von Quadriceps am 29.03.19 23:09:18Denkt ihr, dass da noch einmal Bewegung reinkommt? Altersheim etc. In China müsste doch laufen?
Antwort auf Beitrag Nr.: 56.537.522 von durran am 23.12.17 17:18:11...dafür ist das Ding steuerfrei!
...habe auch noch 4000 leichen im depot
...habe auch noch 4000 leichen im depot
Trading Spotlight
Antwort auf Beitrag Nr.: 55.728.873 von Magreta am 13.09.17 08:47:11
2004 dann COL Capital Limited"
dann 2015 CMHG
erreicht habe ichausser der Dividende nichts mit der Aktie. Wie lange muss ich wohl noch schlafen.
20 Jahre im Depot
Gekauft als ChinaOnline, 2004 dann COL Capital Limited"
dann 2015 CMHG
erreicht habe ichausser der Dividende nichts mit der Aktie. Wie lange muss ich wohl noch schlafen.
Antwort auf Beitrag Nr.: 55.212.893 von Schmusekätzchen am 27.06.17 11:22:50
Dort gibt es in China ein erhebliches Potential. Wäre nur schön, wenn sich dies auch mal im Kurs niederschlägt.
Wo geht die Reise hin?
Ich hatte die Ausrichtung China Medical&HealthCa auch eher in Richtung Senioren gesehen.Dort gibt es in China ein erhebliches Potential. Wäre nur schön, wenn sich dies auch mal im Kurs niederschlägt.
Naja, das kann man jetzt sehen wie man(n) will, aber Frauen haben eben ab und an eine andere Sichtweise und diese läßt mich fragen, wie woll die diese Zinslast stemmen. Aber lest am besten selbst die aktuelle Bekanntmachung von China Medical & HealthCare Group von heute, Di. 27.06.2017, bzw. - um formal korrekt zu bleiben - von gestern, Mo. 26.06.2017 NACH Handelsschluss:
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take
no responsibility for the contents of this announcement, make no representation as to its accuracy
or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising
from or in reliance upon the whole or any part of the contents of this announcement.
(Incorporated in Bermuda with limited liability)
(Stock Code: 383)
China Medical & HealthCare Group Limited
SECOND SUPPLEMENTAL AGREEMENT
IN RELATION TO THE LOAN AGREEMENT
The Board announces that on 26 June 2017 (after trading hours), the Lender and the Borrower
(a non wholly-owned subsidiary of the Company) entered into the Second Supplemental
Agreement pursuant to which the parties agreed to (i) extend the Repayment Date under the
Loan Agreement as amended by the Supplemental Agreement from 23 June 2017 to 23 July
2018 and (ii) amend the interest rate for the first interest period commencing on 23 June 2017
to the date falling one (1) month thereafter to 25.805% per annum and to 12% per annum for
the reminder of the term.
This announcement is made by the board of Directors pursuant to Rule 13.09 and Rule 14.36 of
the Listing Rules.
Unless otherwise stated, definitions used in the Company’s announcements dated 23 December
2015 and 12 January 2017 respectively shall have the same meanings when used in this
announcement.
The Board announces that on 26 June 2017 (after trading hours), the Lender and the Borrower
(a non wholly-owned subsidiary of the Company) entered into the second supplemental loan
agreement (the “Second Supplemental Agreement”) pursuant to which the parties agreed to
(i) extend the Repayment Date under the Loan Agreement as amended by the Supplemental
Agreement from 23 June 2017 to 23 July 2018 and (ii) amend the interest rate for the first
interest period commencing on 23 June 2017 to the date falling one (1) month thereafter to
25.805% per annum and to 12% per annum for the reminder of the term. The Loan has been used
and applied by the Borrower as its general working capital. The terms of the Second Supplemental
Agreement were arrived between the parties after arm’s length negotiation.
– 2 –
The Directors consider that the terms of the Second Supplemental Agreement are fair, reasonable
and beneficial to the Company and are in the interests of the shareholders as a whole.
Save as disclosed herein, all other terms and conditions of the Loan Agreement as amended by
the Supplemental Agreement remain unchanged.
By Order of the Board
China Medical & HealthCare Group Limited
Dr. Lim Cheok Peng
Chairman
Hong Kong, 26 June 2017
As at the date of this announcement, the Board comprises: -
Executive Directors
Ms. Chong Sok Un (Deputy Chairman), Dr. Jonathan Weiyan Seah (Chief Executive Officer),
Dato’ Wong Peng Chong and Mr. Kong Muk Yin
Non-Executive Directors
Dr. Lim Cheok Peng (Chairman) and Mr. Liao Feng
Independent Non-Executive Directors
Mr. Lau Siu Ki, Mr. Zhang Jian and Dr. Xia Xiaoning
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take
no responsibility for the contents of this announcement, make no representation as to its accuracy
or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising
from or in reliance upon the whole or any part of the contents of this announcement.
(Incorporated in Bermuda with limited liability)
(Stock Code: 383)
China Medical & HealthCare Group Limited
SECOND SUPPLEMENTAL AGREEMENT
IN RELATION TO THE LOAN AGREEMENT
The Board announces that on 26 June 2017 (after trading hours), the Lender and the Borrower
(a non wholly-owned subsidiary of the Company) entered into the Second Supplemental
Agreement pursuant to which the parties agreed to (i) extend the Repayment Date under the
Loan Agreement as amended by the Supplemental Agreement from 23 June 2017 to 23 July
2018 and (ii) amend the interest rate for the first interest period commencing on 23 June 2017
to the date falling one (1) month thereafter to 25.805% per annum and to 12% per annum for
the reminder of the term.
This announcement is made by the board of Directors pursuant to Rule 13.09 and Rule 14.36 of
the Listing Rules.
Unless otherwise stated, definitions used in the Company’s announcements dated 23 December
2015 and 12 January 2017 respectively shall have the same meanings when used in this
announcement.
The Board announces that on 26 June 2017 (after trading hours), the Lender and the Borrower
(a non wholly-owned subsidiary of the Company) entered into the second supplemental loan
agreement (the “Second Supplemental Agreement”) pursuant to which the parties agreed to
(i) extend the Repayment Date under the Loan Agreement as amended by the Supplemental
Agreement from 23 June 2017 to 23 July 2018 and (ii) amend the interest rate for the first
interest period commencing on 23 June 2017 to the date falling one (1) month thereafter to
25.805% per annum and to 12% per annum for the reminder of the term. The Loan has been used
and applied by the Borrower as its general working capital. The terms of the Second Supplemental
Agreement were arrived between the parties after arm’s length negotiation.
– 2 –
The Directors consider that the terms of the Second Supplemental Agreement are fair, reasonable
and beneficial to the Company and are in the interests of the shareholders as a whole.
Save as disclosed herein, all other terms and conditions of the Loan Agreement as amended by
the Supplemental Agreement remain unchanged.
By Order of the Board
China Medical & HealthCare Group Limited
Dr. Lim Cheok Peng
Chairman
Hong Kong, 26 June 2017
As at the date of this announcement, the Board comprises: -
Executive Directors
Ms. Chong Sok Un (Deputy Chairman), Dr. Jonathan Weiyan Seah (Chief Executive Officer),
Dato’ Wong Peng Chong and Mr. Kong Muk Yin
Non-Executive Directors
Dr. Lim Cheok Peng (Chairman) and Mr. Liao Feng
Independent Non-Executive Directors
Mr. Lau Siu Ki, Mr. Zhang Jian and Dr. Xia Xiaoning
Homepage
Hier ist es ja richtig ruhig geworden ... In den letzten Wochen hat sich der Kurs der Aktie bei positivem Marktumfeld schleichend nach unten entwickelt. Ob das darauf zurückzuführen ist, dass es keine interessante Story für internationale Investoren mehr gibt?
Ich muss zugeben: Inwieweit Krankenhäuser unbegrenztes Wachtumspotential versprechen, weiß ich auch noch nicht.
Die Homepage ist auf jedenfall mal einen Blick wert. Deutlich besser aufgebaut als zu COL-Zeiten.
http://www.cmhg.com.hk/en/
Beste Grüße
Ace
Antwort auf Beitrag Nr.: 53.577.942 von durran am 28.10.16 21:04:39Was meint IHr: LOhnt sich hier noch der Einstieg ? Verfolge den Wert jetzt ca. 9 Monate und sehe hier noch weitere Kurschancen. Wie fallen die Analystenmeinungen zu diesem Wert aus und wo seht ihr den Wert ?
Durchsuchen
